Effects of Lutein in Retinitis Pigmentosa
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Phase I/II double-masked, randomized, placebo-controlled, cross-over trial to determine effects of lutein on vision in retinitis pigmentosa, including safety and effective dosage assessment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2001
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2001
CompletedFirst Submitted
Initial submission to the registry
January 9, 2002
CompletedFirst Posted
Study publicly available on registry
January 10, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2002
CompletedAugust 18, 2006
August 1, 2006
January 9, 2002
August 16, 2006
Conditions
Interventions
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins Wilmer Eye Institute, Lions Vision Center
Baltimore, Maryland, 21205, United States
Related Publications (1)
Bahrami H, Melia M, Dagnelie G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol. 2006 Jun 7;6:23. doi: 10.1186/1471-2415-6-23.
PMID: 16759390DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- NIH
Study Record Dates
First Submitted
January 9, 2002
First Posted
January 10, 2002
Study Start
April 1, 2001
Study Completion
October 1, 2002
Last Updated
August 18, 2006
Record last verified: 2006-08